Medgenics Reports 2013 Financial Results

[GlobeNewswire] – WAYNE, Pa. and MISGAV, Israel — Medgenics, Inc. (NYSE MKT: MDGN) , the developer of a novel platform technology for the sustained production and delivery of therapeutic proteins in patients using ex-vivo … more

View todays social media effects on MDGN

View the latest stocks trending across Twitter. Click to view dashboard

See who Medgenics is hiring next, click here to view